Laurel Yartz Purchases 1,350 Shares of Lakeland Industries (NASDAQ:LAKE) Stock

Lakeland Industries, Inc. (NASDAQ:LAKE) insider Laurel Yartz bought 1,350 shares of the firm’s stock in a transaction on Monday, December 22nd. The stock was acquired at an average price of $8.15 per share, for a total transaction of $11,002.50. Following the transaction, the insider owned 15,826 shares of the company’s stock, valued at approximately $128,981.90. The trade was a 9.33% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Lakeland Industries Price Performance

Shares of LAKE traded up $0.59 during mid-day trading on Tuesday, reaching $8.68. The company had a trading volume of 150,076 shares, compared to its average volume of 152,611. The company has a market capitalization of $85.15 million, a price-to-earnings ratio of -1.98 and a beta of 1.33. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.48 and a current ratio of 3.83. The company’s 50 day simple moving average is $14.39 and its 200 day simple moving average is $14.54. Lakeland Industries, Inc. has a 1-year low of $7.77 and a 1-year high of $27.28.

Lakeland Industries (NASDAQ:LAKE) last issued its quarterly earnings data on Wednesday, September 21st. The medical instruments supplier reported $0.36 EPS for the quarter. The business had revenue of $27.47 million during the quarter. Lakeland Industries had a negative net margin of 19.41% and a negative return on equity of 7.80%. Analysts expect that Lakeland Industries, Inc. will post 0.48 EPS for the current year.

Lakeland Industries Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 24th. Investors of record on Monday, November 17th were given a dividend of $0.03 per share. The ex-dividend date was Monday, November 17th. This represents a $0.12 dividend on an annualized basis and a yield of 1.4%. Lakeland Industries’s payout ratio is currently -2.73%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on LAKE. DA Davidson reissued a “neutral” rating and set a $14.00 price target (down from $20.00) on shares of Lakeland Industries in a research note on Wednesday, December 10th. Lake Street Capital cut their target price on shares of Lakeland Industries from $26.00 to $19.00 and set a “buy” rating on the stock in a research report on Wednesday, December 10th. Wall Street Zen lowered shares of Lakeland Industries from a “hold” rating to a “strong sell” rating in a report on Saturday, December 13th. Weiss Ratings reiterated a “sell (d)” rating on shares of Lakeland Industries in a report on Wednesday, October 8th. Finally, UBS Group set a $14.00 price objective on shares of Lakeland Industries in a research note on Wednesday, December 10th. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $16.50.

Institutional Investors Weigh In On Lakeland Industries

Several institutional investors and hedge funds have recently made changes to their positions in LAKE. Kennedy Capital Management LLC bought a new stake in Lakeland Industries in the third quarter valued at $2,287,000. Ancora Advisors LLC increased its position in Lakeland Industries by 85.1% in the 1st quarter. Ancora Advisors LLC now owns 276,688 shares of the medical instruments supplier’s stock valued at $5,620,000 after buying an additional 127,195 shares in the last quarter. Geode Capital Management LLC raised its stake in Lakeland Industries by 115.9% during the 2nd quarter. Geode Capital Management LLC now owns 217,786 shares of the medical instruments supplier’s stock worth $2,964,000 after buying an additional 116,901 shares during the period. Russell Investments Group Ltd. boosted its holdings in Lakeland Industries by 1,720.2% in the first quarter. Russell Investments Group Ltd. now owns 114,017 shares of the medical instruments supplier’s stock worth $2,316,000 after acquiring an additional 107,753 shares in the last quarter. Finally, Royce & Associates LP grew its stake in Lakeland Industries by 10.0% in the third quarter. Royce & Associates LP now owns 1,178,670 shares of the medical instruments supplier’s stock valued at $17,444,000 after acquiring an additional 107,100 shares during the period. Institutional investors own 71.69% of the company’s stock.

About Lakeland Industries

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.